Centrus Energy posted Q2 2026 revenue of $176.1 million, up 14% from the previous year, driven by increased uranium sales and new contracts. The company signed a $900 million High-Assay, Low-Enriched Uranium (HALEU) enrichment contract with the U.S. Department of Energy, boosting its backlog to $4.5 billion. Despite a GAAP net income decline to $16.8 million, adjusted net income rose to $38.7 million, reflecting strong operational progress and strategic investments in uranium enrichment capacity expansions. Centrus plans to complete its first new centrifuge by year-end 2026 and increase hiring at its Ohio and Tennessee facilities, positioning itself to capitalize on growing demand for nuclear fuel.
Shares of NuScale Power fell 7% after a recent policy-driven rally reversed, with the stock now down 40% year-to-date. The decline follows the House passing the Ratepayer Protection Act, which initially boosted nuclear developers by shifting energy c...
Centrus Energy and Antares Nuclear have signed a multi-year contract for Centrus to supply High-Assay Low-Enriched Uranium (HALEU) to Antares, with deliveries starting before 2030. This deal supports Antares' advanced reactor projects for defense and...
